| Two patients with acute meningoencephalitis concomitant with SARS‐CoV‐2 infection R Bernard‐Valnet, B Pizzarotti, A Anichini, Y Demars, E Russo, ... European journal of neurology 27 (9), e43, 2020 | 239 | 2020 |
| Aquaporin-4 antibody–negative neuromyelitis optica: distinct assay sensitivity–dependent entity R Marignier, R Bernard-Valnet, P Giraudon, N Collongues, C Papeix, ... Neurology 80 (24), 2194-2200, 2013 | 203 | 2013 |
| Pattern of cognitive deficits in severe COVID-19 V Beaud, S Crottaz-Herbette, V Dunet, J Vaucher, R Bernard-Valnet, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (5), 567-568, 2021 | 198 | 2021 |
| CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice R Bernard-Valnet, L Yshii, C Quériault, XH Nguyen, S Arthaud, ... Proceedings of the National Academy of Sciences 113 (39), 10956-10961, 2016 | 146 | 2016 |
| A systematic review of neurological manifestations of SARS‐CoV‐2 infection: the devil is hidden in the details M Romoli, I Jelcic, R Bernard‐Valnet, D García Azorín, L Mancinelli, ... European journal of neurology 27 (9), 1712-1726, 2020 | 128* | 2020 |
| High-dimensional single-cell analysis reveals the immune signature of narcolepsy FJ Hartmann, R Bernard-Valnet, C Quériault, D Mrdjen, LM Weber, E Galli, ... Journal of experimental medicine 213 (12), 2621-2633, 2016 | 120 | 2016 |
| Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability H Zéphir, R Bernard-Valnet, C Lebrun, O Outteryck, B Audoin, B Bourre, ... Journal of neurology 262, 2329-2335, 2015 | 107 | 2015 |
| Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications Á Cobo-Calvo, M Sepúlveda, R Bernard-Valnet, A Ruiz, D Brassat, ... Multiple Sclerosis Journal 22 (3), 312-319, 2016 | 89 | 2016 |
| SARS‐CoV‐2 and Guillain–Barré syndrome: AIDP variant with a favourable outcome AM Lascano, JB Epiney, M Coen, J Serratrice, R Bernard‐Valnet, ... European journal of neurology 27 (9), 1751-1753, 2020 | 82 | 2020 |
| Significance of myelin oligodendrocyte glycoprotein antibodies in CSF: a retrospective multicenter study S Carta, Á Cobo Calvo, T Armangué, A Saiz, C Lechner, K Rostásy, ... Neurology 100 (11), e1095-e1108, 2023 | 56 | 2023 |
| An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assays R Höftberger, L Sabater, R Marignier, F Aboul-Enein, R Bernard-Valnet, ... PLoS One 8 (11), e79083, 2013 | 49 | 2013 |
| Neuromyelitis optica: a positive appraisal of seronegative cases R Bernard‐Valnet, RS Liblau, S Vukusic, R Marignier European Journal of Neurology 22 (12), 1511-e83, 2015 | 48 | 2015 |
| Advances in treatment of progressive multifocal leukoencephalopathy R Bernard‐Valnet, IJ Koralnik, R Du Pasquier Annals of neurology 90 (6), 865-873, 2021 | 47 | 2021 |
| Encephalopathies associated with severe COVID-19 present neurovascular unit alterations without evidence for strong neuroinflammation R Bernard-Valnet, S Perriot, M Canales, B Pizzarotti, L Caranzano, ... Neurology: Neuroimmunology & Neuroinflammation 8 (5), e1029, 2021 | 44 | 2021 |
| Neurons and T cells: Understanding this interaction for inflammatory neurological diseases L Yshii, C Gebauer, R Bernard‐Valnet, R Liblau European journal of immunology 45 (10), 2712-2720, 2015 | 42 | 2015 |
| Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis B Singh, S Lant, S Cividini, JWS Cattrall, LC Goodwin, L Benjamin, ... PLoS One 17 (6), e0263595, 2022 | 40 | 2022 |
| Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors X Boumaza, B Bonneau, D Roos‐Weil, C Pinnetti, S Rauer, L Nitsch, ... Annals of neurology 93 (2), 257-270, 2023 | 34 | 2023 |
| Paraneoplastic neuromyelitis optica and ovarian teratoma: A case series R Bernard-Valnet, A Cobo-Calvo, A Siegfried, R Marasescu, M Bonnan, ... Multiple sclerosis and related disorders 31, 97-100, 2019 | 26 | 2019 |
| Area postrema syndrome: another feature of anti-GFAP encephalomyelitis J Ciron, F Sourdrille, D Biotti, T Tchoumi, A Ruiz, R Bernard-Valnet, ... Multiple Sclerosis Journal 26 (2), 253-255, 2020 | 23 | 2020 |
| Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis A Mathias, V Pantazou, S Perriot, M Canales, S Jones, L Oberholster, ... Neurology: Neuroimmunology & Neuroinflammation 10 (2), e200084, 2023 | 20 | 2023 |
Liblau RolandUT3 Professor, CHU Purpan, CPTP(INSERM-UPS-CNRS), TMBI (Univ, Toulouse)在 inserm.fr 的电子邮件经过验证
